Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

More articles from Editorial

  • You have access
    Methotrexate in Our Hearts
    LOTTA LJUNG and MARIE HOLMQVIST
    The Journal of Rheumatology May 1 2019, 46 (5) 447-449; DOI: https://doi.org/10.3899/jrheum.181269
  • You have access
    Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?
    ROY FLEISCHMANN
    The Journal of Rheumatology May 1 2019, 46 (5) 443-446; DOI: https://doi.org/10.3899/jrheum.181061
  • You have access
    The Role of Ultrasound in Psoriatic Arthritis — Do We Need a Score?
    MARIA ANTONIETTA D’AGOSTINO and LAURA C. COATES
    The Journal of Rheumatology April 1 2019, 46 (4) 337-339; DOI: https://doi.org/10.3899/jrheum.181044
  • You have access
    Low-dose Glucocorticoid Use Does Not Reduce Biologic Use in Early RA, Nor Do Biologics Reduce the Need for Glucocorticoids
    VIVIAN P. BYKERK
    The Journal of Rheumatology April 1 2019, 46 (4) 331-332; DOI: https://doi.org/10.3899/jrheum.181262
  • You have access
    The Elusive but Painful Subtalar Joint in Rheumatoid Arthritis
    GURJIT S. KAELEY, VEENA K. RANGANATH and JOHANNES ROTH
    The Journal of Rheumatology April 1 2019, 46 (4) 333-336; DOI: https://doi.org/10.3899/jrheum.181156
  • You have access
    Hydroxychloroquine — How Much Is Too Much?
    VANEET KAUR SANDHU and MICHAEL H. WEISMAN
    The Journal of Rheumatology April 1 2019, 46 (4) 340-342; DOI: https://doi.org/10.3899/jrheum.180639
  • You have access
    Etiology of Pseudarthrosis in Ankylosing Spondylitis: What Is the Main Cause?
    TAE-HWAN KIM and SEUNGHUN LEE
    The Journal of Rheumatology March 1 2019, 46 (3) 226-228; DOI: https://doi.org/10.3899/jrheum.180987
  • You have access
    It Is Time to Modify Treatment to Enable More Women with Rheumatoid Arthritis to Have Successful Pregnancies
    MEGAN E.B. CLOWSE
    The Journal of Rheumatology March 1 2019, 46 (3) 223-225; DOI: https://doi.org/10.3899/jrheum.181036
  • You have access
    Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?
    PATRICK H. DESSEIN, ANNE E. STANWIX and AHMED SOLOMON
    The Journal of Rheumatology March 1 2019, 46 (3) 219-222; DOI: https://doi.org/10.3899/jrheum.181163
  • You have access
    Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
    TIMOTHY BEUKELMAN and PETER A. NIGROVIC
    The Journal of Rheumatology February 1 2019, 46 (2) 124-126; DOI: https://doi.org/10.3899/jrheum.180922

Pages

  • Previous
  • Next
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 56

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire